[HTML][HTML] Update on prevalence of pain in patients with cancer 2022: a systematic literature review and meta-analysis

RAH Snijders, L Brom, M Theunissen… - Cancers, 2023 - mdpi.com
Simple Summary Pain associated with cancer diagnoses is a serious concern and one of
the most common symptoms reported by cancer patients. The insufficient relief of cancer …

[HTML][HTML] Applications of artificial intelligence in philadelphia-negative myeloproliferative neoplasms

B Elsayed, AM Elshoeibi, M Elhadary, K Ferih… - Diagnostics, 2023 - mdpi.com
Philadelphia-negative (Ph-) myeloproliferative neoplasms (MPNs) are a group of
hematopoietic malignancies identified by clonal proliferation of blood cell lineages and …

Severe acute respiratory syndrome coronavirus 2 omicron variant in patients with philadelphia-negative myeloproliferative neoplasm: a single center experience

EAH Ali, I Khamees, A Alshurafa, H Qasim… - Oncology, 2022 - karger.com
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the viral
agent responsible for the coronavirus disease of 2019. The disease is primarily a respiratory …

Bomedemstat as an investigative treatment for myeloproliferative neoplasms

HY Rienhoff Jr, H Gill - Expert Opinion on Investigational Drugs, 2023 - Taylor & Francis
Introduction Myeloproliferative neoplasm (MPN) is a heterogeneous group of hematopoietic
stem cell disorders characterized by clonal proliferation of one of more of the hematopoietic …

Assessing Bone Marrow Activity with [18F]FLT PET in Patients with Essential Thrombocythemia and Prefibrotic Myelofibrosis: A Proof of Concept

MA Yassin, SA Nehmeh, AJ Nashwan… - … in Cancer Research …, 2022 - journals.sagepub.com
Objectives: This study aims to assess the value of FLT-PET as a non-invasive tool to
differentiate between patients with ET and Pre-PMF. This study is a pilot study to have a …

Essential thrombocythemia with (type2) calreticulin presented as stuttering priapism case report and review of literature

EA Ali, AJ Nashwan, MA Yassin - Clinical Case Reports, 2021 - Wiley Online Library
Essential thrombocythemia with (type2) calreticulin presented as stuttering priapism case report
and review of literature - Ali - 2021 - Clinical Case Reports - Wiley Online Library Skip to Article …

Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasms

D Shi, H Shi, X Liu, M Duan, J Zhuang, X Du… - Leukemia & …, 2021 - Taylor & Francis
We explored variables associated with patient-reported outcomes (PROs) including
symptom burden, impact on daily life and work, obstacles during therapy, satisfaction level …

[HTML][HTML] Mutation profile in BCR-ABL1-negative myeloproliferative neoplasms: A single-center experience from India

M Maddali, UP Kulkarni, N Ravindra… - … /oncology and stem cell …, 2021 - Elsevier
Abstract Objective/Background Recurrent somatic mutations in the JAK2, calreticulin
(CALR), and the MPL genes are described as drivers of BCR-ABL1-negative …

[HTML][HTML] Myocardial infarction as an initial presentation of essential thrombocythemia with calreticulin (CALR) mutation (none type 1, none type 2)

M Afana, M Abu-Tineh, A Ellahie, O Ismail, D Sideeg… - Cureus, 2023 - ncbi.nlm.nih.gov
Essential thrombocythemia (ET) is one of the classical Philadelphia-negative
myeloproliferative neoplasms with different mutations that can be associated with it, like …

[HTML][HTML] Ruxolitinib (a JAK2 inhibitor) as an emerging therapy for refractory pruritis in a patient with low-risk polycythemia vera: a case report

AF Al-Mashdali, WR Kashgary, MA Yassin - Medicine, 2021 - journals.lww.com
Conclusion: Different treatment modalities have shown to be beneficial in treating PV-related
pruritis, but the clinical outcomes are highly variable. This case report aims to shed light on …